The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...
A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...
Eczema, a prevalent skin condition affecting millions worldwide, is characterized by dry, itching, and inflamed skin, frequently appearing on hands. Incorrect use of hand soap can exacerbate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results